小核细胞RNA Snora73通过海绵化miR-3074-5p和调节PBX1表达来促进牛皮的进展,并调节PBX1表达
Lihua Zhang1,2, Hui Guo3, Xiaoguang Zhang1,2
1Department of Dermatology, Clinical Medical Research Center of Dermatology and Venereal Disease in Hebei Province, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
Functional & integrative genomics
|January 19, 2024
概括
一种新的小核细胞RNA,Snora73,在慢性牛皮中被高调. 斯诺拉73通过菌miR-3074-5p促进牛皮细胞的进展,影响miR-3074-5p/PBX1通路.
科学领域:
- 皮肤病学 皮肤病学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 慢性牛皮是一种免疫媒介的皮肤疾病,其分子机制尚未完全理解.
- 识别关键的分子参与者对于了解牛皮病原体至关重要.
研究的目的:
- 为了研究小RNAs在慢性牛皮病原发生中的作用.
- 阐明导致牛皮病进展的分子机制.
主要方法:
- 用小RNA微阵列测试来识别牛皮样本中差异表达的RNA.
- 生物信息学分析,光 in situ 杂交和双露西法酶记者测试被用来预测和确认miRNA目标.
- 细胞的增殖和迁移被使用CCK-8和转井试验来评估.
主要成果:
- 在牛皮患者样本中发现了一种新型的小核细胞RNA,Snora73,在牛皮患者样本中被调高.
- 过度表达Snora73增强了牛皮细胞的活力和迁移,而它的敲击抑制了这些过程.
- 斯诺拉73作为miR-3074-5p的海绵,PBX1在牛皮细胞中是miR-3074-5p的直接目标.
- miR-3074-5p抑制了细胞的增殖和迁移,而PBX1则促进了它们.
结论:
- 斯诺拉73通过miR-3074-5p/PBX1信号通路在牛皮的进展中发挥着关键作用.
- 这一途径代表了慢性牛皮的潜在治疗标.
相关概念视频
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
The Nucleolus
8.8K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.8K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
piRNA - Piwi-interacting RNAs
6.9K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.9K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K


